As an international peer-reviewed open access journal, Antibody Therapeutics provides a forum for the publication of the latest advances and challenges in the discovery, research, development, manufacturing, and methodology of therapeutic antibodies for the global scientific community. Topics include target and antibody discovery, mechanistic research, new technologies and methods, manufacturing, clinical trials, regulation, policies, and more. Antibody Therapeutics article types include original research, reviews, cutting-edge technologies, new methods. Indexed by ESCI (2024 Impact Factor: 4.5), Scopus (2024 CiteScore: 8.4) and PubMed.
Company Details
- Employees
- 4
- Founded
- -
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://academic.oup.com/abt
Antibody Therapeutics Questions
Antibody Therapeutics's website is https://academic.oup.com/abt
Antibody Therapeutics's LinkedIn profile is https://www.linkedin.com/company/antibody-therapeutics
Antibody Therapeutics has
4 employees.
View email and phone details for 4
employees at Antibody Therapeutics.
Antibody Therapeutics's industry is
Research Services
Antibody Therapeutics's top competitors are
Regeneron,
Drugpatents-In-The-Last-14days,
Institute For Protein Design, University Of Washington,
Genentech,
Chinese Antibody Society,
Antibody Engineering & Therapeutics,
Wuxi Xdc,
Abbvie,
Merck Group,
The Antibody Society.
Antibody Therapeutics's categories are Research Services
Antibody Therapeutics's founding year is 2018
